loader

nasdaq:nmrd

LATEST ARTICLES
medical device investing

Nemaura Reports Third Quarter 2018 Financial Results

Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial

Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering

Nemaura Signs License and Distribution Agreement for SugarBEAT Commercial Launch in Qatar

NASDAQ:NMRD
medical device investing

Nemaura Develops Functionality for SugarBEAT

Nemaura Medical Reports Second Quarter 2018 Financial Results

medical device investing

Nemaura Signs Letter of Intent for SugarBEAT Commercial Launch in Qatar

NASDAQ:NMRD
medical device investing

Nemaura’s Diabetes Device Receives Positive Interim Data

medical device investing

Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT FDA Clinical Trial

NASDAQ:CASM
medical device investing

Medical Device Update: Q2 2018 in Review

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES